Table of Content

1 Market Overview

• 1.1 Product Definition and Market Characteristics
• 1.2 Global HIV Therapeutics Market Size
• 1.3 Market Segmentation
• 1.4 Global Macroeconomic Analysis
• 1.5 SWOT Analysis

2. Market Dynamics

• 2.1 Market Drivers
• 2.2 Market Constraints and Challenges
• 2.3 Emerging Market Trends
• 2.4 Impact of COVID-19
  • 2.4.1 Short-term Impact
  • 2.4.2 Long-term Impact

3 Associated Industry Assessment

• 3.1 Supply Chain Analysis
• 3.2 Industry Active Participants
  • 3.2.1 Suppliers of Raw Materials
  • 3.2.2 Key Distributors/Retailers
• 3.3 Alternative Analysis
• 3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape

• 4.1 Industry Leading Players
• 4.2 Industry News
  • 4.2.1 Key Product Launch News
  • 4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies

• 5.1 F. Hoffmann-La Roche Ltd.
  • 5.1.1 F. Hoffmann-La Roche Ltd. Company Profile
  • 5.1.2 F. Hoffmann-La Roche Ltd. Business Overview
  • 5.1.3 F. Hoffmann-La Roche Ltd. HIV Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.1.4 F. Hoffmann-La Roche Ltd. HIV Therapeutics Products Introduction
• 5.2 GlaxoSmithKline
  • 5.2.1 GlaxoSmithKline Company Profile
  • 5.2.2 GlaxoSmithKline Business Overview
  • 5.2.3 GlaxoSmithKline HIV Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.2.4 GlaxoSmithKline HIV Therapeutics Products Introduction
• 5.3 AbbVie
  • 5.3.1 AbbVie Company Profile
  • 5.3.2 AbbVie Business Overview
  • 5.3.3 AbbVie HIV Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.3.4 AbbVie HIV Therapeutics Products Introduction
• 5.4 Teva Pharmaceutical Industries Ltd.
  • 5.4.1 Teva Pharmaceutical Industries Ltd. Company Profile
  • 5.4.2 Teva Pharmaceutical Industries Ltd. Business Overview
  • 5.4.3 Teva Pharmaceutical Industries Ltd. HIV Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.4.4 Teva Pharmaceutical Industries Ltd. HIV Therapeutics Products Introduction
• 5.5 Merck & Co.
  • 5.5.1 Merck & Co. Company Profile
  • 5.5.2 Merck & Co. Business Overview
  • 5.5.3 Merck & Co. HIV Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.5.4 Merck & Co. HIV Therapeutics Products Introduction
• 5.6 Pfizer
  • 5.6.1 Pfizer Company Profile
  • 5.6.2 Pfizer Business Overview
  • 5.6.3 Pfizer HIV Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.6.4 Pfizer HIV Therapeutics Products Introduction
• 5.7 Gilead Sciences
  • 5.7.1 Gilead Sciences Company Profile
  • 5.7.2 Gilead Sciences Business Overview
  • 5.7.3 Gilead Sciences HIV Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.7.4 Gilead Sciences HIV Therapeutics Products Introduction
• 5.8 Cipla Limited
  • 5.8.1 Cipla Limited Company Profile
  • 5.8.2 Cipla Limited Business Overview
  • 5.8.3 Cipla Limited HIV Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.8.4 Cipla Limited HIV Therapeutics Products Introduction
• 5.9 Boehringer Ingelheim International GmbH
  • 5.9.1 Boehringer Ingelheim International GmbH Company Profile
  • 5.9.2 Boehringer Ingelheim International GmbH Business Overview
  • 5.9.3 Boehringer Ingelheim International GmbH HIV Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.9.4 Boehringer Ingelheim International GmbH HIV Therapeutics Products Introduction
• 5.10 ViiV Healthcare
  • 5.10.1 ViiV Healthcare Company Profile
  • 5.10.2 ViiV Healthcare Business Overview
  • 5.10.3 ViiV Healthcare HIV Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.10.4 ViiV Healthcare HIV Therapeutics Products Introduction
• 5.11 Johnson & Johnson
  • 5.11.1 Johnson & Johnson Company Profile
  • 5.11.2 Johnson & Johnson Business Overview
  • 5.11.3 Johnson & Johnson HIV Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.11.4 Johnson & Johnson HIV Therapeutics Products Introduction
• 5.12 Bristol-Myers Squibb
  • 5.12.1 Bristol-Myers Squibb Company Profile
  • 5.12.2 Bristol-Myers Squibb Business Overview
  • 5.12.3 Bristol-Myers Squibb HIV Therapeutics Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
  • 5.12.4 Bristol-Myers Squibb HIV Therapeutics Products Introduction

6 Market Analysis and Forecast, By Product Types

• 6.1 Global HIV Therapeutics Sales, Revenue and Market Share by Types (2015-2020)
  • 6.1.1 Global HIV Therapeutics Sales and Market Share by Types (2015-2020)
  • 6.1.2 Global HIV Therapeutics Revenue and Market Share by Types (2015-2020)
  • 6.1.3 Global HIV Therapeutics Price by Types (2015-2020)
• 6.2 Global HIV Therapeutics Market Forecast by Types (2020-2025)
  • 6.2.1 Global HIV Therapeutics Market Forecast Sales and Market Share by Types (2020-2025)
  • 6.2.2 Global HIV Therapeutics Market Forecast Revenue and Market Share by Types (2020-2025)
• 6.3 Global HIV Therapeutics Sales, Price and Growth Rate by Types (2015-2020)
  • 6.3.1 Global HIV Therapeutics Sales, Price and Growth Rate of Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
  • 6.3.2 Global HIV Therapeutics Sales, Price and Growth Rate of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
  • 6.3.3 Global HIV Therapeutics Sales, Price and Growth Rate of Entry and Fusion Inhibitors
  • 6.3.4 Global HIV Therapeutics Sales, Price and Growth Rate of Protease Inhibitors (PIs)
  • 6.3.5 Global HIV Therapeutics Sales, Price and Growth Rate of Integrase Inhibitors
  • 6.3.6 Global HIV Therapeutics Sales, Price and Growth Rate of Coreceptor Antagonists
• 6.4 Global HIV Therapeutics Market Revenue and Sales Forecast, by Types (2020-2025)
  • 6.4.1 Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Market Revenue and Sales Forecast (2020-2025)
  • 6.4.2 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Market Revenue and Sales Forecast (2020-2025)
  • 6.4.3 Entry and Fusion Inhibitors Market Revenue and Sales Forecast (2020-2025)
  • 6.4.4 Protease Inhibitors (PIs) Market Revenue and Sales Forecast (2020-2025)
  • 6.4.5 Integrase Inhibitors Market Revenue and Sales Forecast (2020-2025)
  • 6.4.6 Coreceptor Antagonists Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications

• 7.1 Global HIV Therapeutics Sales, Revenue and Market Share by Applications (2015-2020)
  • 7.1.1 Global HIV Therapeutics Sales and Market Share by Applications (2015-2020)
  • 7.1.2 Global HIV Therapeutics Revenue and Market Share by Applications (2015-2020)
• 7.2 Global HIV Therapeutics Market Forecast by Applications (2020-2025)
  • 7.2.1 Global HIV Therapeutics Market Forecast Sales and Market Share by Applications (2020-2025)
  • 7.2.2 Global HIV Therapeutics Market Forecast Revenue and Market Share by Applications (2020-2025)
• 7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
  • 7.3.1 Global HIV Therapeutics Revenue, Sales and Growth Rate of Hospitals (2015-2020)
  • 7.3.2 Global HIV Therapeutics Revenue, Sales and Growth Rate of Clinics (2015-2020)
  • 7.3.3 Global HIV Therapeutics Revenue, Sales and Growth Rate of Labs (2015-2020)
• 7.4 Global HIV Therapeutics Market Revenue and Sales Forecast, by Applications (2020-2025)
  • 7.4.1 Hospitals Market Revenue and Sales Forecast (2020-2025)
  • 7.4.2 Clinics Market Revenue and Sales Forecast (2020-2025)
  • 7.4.3 Labs Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions

• 8.1 Global HIV Therapeutics Sales by Regions (2015-2020)
• 8.2 Global HIV Therapeutics Market Revenue by Regions (2015-2020)
• 8.3 Global HIV Therapeutics Market Forecast by Regions (2020-2025)

9 North America HIV Therapeutics Market Analysis

• 9.1 Market Overview and Prospect Analysis
• 9.2 North America HIV Therapeutics Market Sales and Growth Rate (2015-2020)
• 9.3 North America HIV Therapeutics Market Revenue and Growth Rate (2015-2020)
• 9.4 North America HIV Therapeutics Market Forecast
• 9.5 The Influence of COVID-19 on North America Market
• 9.6 North America HIV Therapeutics Market Analysis by Country
  • 9.6.1 U.S. HIV Therapeutics Sales and Growth Rate
  • 9.6.2 Canada HIV Therapeutics Sales and Growth Rate
  • 9.6.3 Mexico HIV Therapeutics Sales and Growth Rate

10 Europe HIV Therapeutics Market Analysis

• 10.1 Market Overview and Prospect Analysis
• 10.2 Europe HIV Therapeutics Market Sales and Growth Rate (2015-2020)
• 10.3 Europe HIV Therapeutics Market Revenue and Growth Rate (2015-2020)
• 10.4 Europe HIV Therapeutics Market Forecast
• 10.5 The Influence of COVID-19 on Europe Market
• 10.6 Europe HIV Therapeutics Market Analysis by Country
  • 10.6.1 Germany HIV Therapeutics Sales and Growth Rate
  • 10.6.2 United Kingdom HIV Therapeutics Sales and Growth Rate
  • 10.6.3 France HIV Therapeutics Sales and Growth Rate
  • 10.6.4 Italy HIV Therapeutics Sales and Growth Rate
  • 10.6.5 Spain HIV Therapeutics Sales and Growth Rate
  • 10.6.6 Russia HIV Therapeutics Sales and Growth Rate

11 Asia-Pacific HIV Therapeutics Market Analysis

• 11.1 Market Overview and Prospect Analysis
• 11.2 Asia-Pacific HIV Therapeutics Market Sales and Growth Rate (2015-2020)
• 11.3 Asia-Pacific HIV Therapeutics Market Revenue and Growth Rate (2015-2020)
• 11.4 Asia-Pacific HIV Therapeutics Market Forecast
• 11.5 The Influence of COVID-19 on Asia Pacific Market
• 11.6 Asia-Pacific HIV Therapeutics Market Analysis by Country
  • 11.6.1 China HIV Therapeutics Sales and Growth Rate
  • 11.6.2 Japan HIV Therapeutics Sales and Growth Rate
  • 11.6.3 South Korea HIV Therapeutics Sales and Growth Rate
  • 11.6.4 Australia HIV Therapeutics Sales and Growth Rate
  • 11.6.5 India HIV Therapeutics Sales and Growth Rate

12 South America HIV Therapeutics Market Analysis

• 12.1 Market Overview and Prospect Analysis
• 12.2 South America HIV Therapeutics Market Sales and Growth Rate (2015-2020)
• 12.3 South America HIV Therapeutics Market Revenue and Growth Rate (2015-2020)
• 12.4 South America HIV Therapeutics Market Forecast
• 12.5 The Influence of COVID-19 on South America Market
• 12.6 South America HIV Therapeutics Market Analysis by Country
  • 12.6.1 Brazil HIV Therapeutics Sales and Growth Rate
  • 12.6.2 Argentina HIV Therapeutics Sales and Growth Rate
  • 12.6.3 Columbia HIV Therapeutics Sales and Growth Rate

13 Middle East and Africa HIV Therapeutics Market Analysis

• 13.1 Market Overview and Prospect Analysis
• 13.2 Middle East and Africa HIV Therapeutics Market Sales and Growth Rate (2015-2020)
• 13.3 Middle East and Africa HIV Therapeutics Market Revenue and Growth Rate (2015-2020)
• 13.4 Middle East and Africa HIV Therapeutics Market Forecast
• 13.5 The Influence of COVID-19 on Middle East and Africa Market
• 13.6 Middle East and Africa HIV Therapeutics Market Analysis by Country
  • 13.6.1 UAE HIV Therapeutics Sales and Growth Rate
  • 13.6.2 Egypt HIV Therapeutics Sales and Growth Rate
  • 13.6.3 South Africa HIV Therapeutics Sales and Growth Rate

14 Conclusions and Recommendations

• 14.1 Key Market Findings and Prospects
• 14.2 Advice for Investors

15 Appendix

• 15.1 Methodology
• 15.2 Research Data Source

List of Tables and Figures

Figure Product Picture

Figure Global HIV Therapeutics Market Size and Growth Rate 2015-2025

Table HIV Therapeutics Key Market Segments

Figure Global HIV Therapeutics Market Revenue ($) Segment by Type from 2015-2020

Figure Global HIV Therapeutics Market Revenue ($) Segment by Applications from 2015-2020

Table SWOT Analysis

Figure Global COVID-19 Status

Figure Supply Chain

Table Major Players Headquarters, and Service Area of HIV Therapeutics

Table Major Players Revenue in 2019

Figure Major Players Revenue Share in 2019

Table F. Hoffmann-La Roche Ltd. Company Profile

Table F. Hoffmann-La Roche Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure F. Hoffmann-La Roche Ltd. Production and Growth Rate

Figure F. Hoffmann-La Roche Ltd. Market Revenue ($) Market Share 2015-2020

Table GlaxoSmithKline Company Profile

Table GlaxoSmithKline Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure GlaxoSmithKline Production and Growth Rate

Figure GlaxoSmithKline Market Revenue ($) Market Share 2015-2020

Table AbbVie Company Profile

Table AbbVie Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure AbbVie Production and Growth Rate

Figure AbbVie Market Revenue ($) Market Share 2015-2020

Table Teva Pharmaceutical Industries Ltd. Company Profile

Table Teva Pharmaceutical Industries Ltd. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Teva Pharmaceutical Industries Ltd. Production and Growth Rate

Figure Teva Pharmaceutical Industries Ltd. Market Revenue ($) Market Share 2015-2020

Table Merck & Co. Company Profile

Table Merck & Co. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Merck & Co. Production and Growth Rate

Figure Merck & Co. Market Revenue ($) Market Share 2015-2020

Table Pfizer Company Profile

Table Pfizer Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Pfizer Production and Growth Rate

Figure Pfizer Market Revenue ($) Market Share 2015-2020

Table Gilead Sciences Company Profile

Table Gilead Sciences Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Gilead Sciences Production and Growth Rate

Figure Gilead Sciences Market Revenue ($) Market Share 2015-2020

Table Cipla Limited Company Profile

Table Cipla Limited Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Cipla Limited Production and Growth Rate

Figure Cipla Limited Market Revenue ($) Market Share 2015-2020

Table Boehringer Ingelheim International GmbH Company Profile

Table Boehringer Ingelheim International GmbH Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Boehringer Ingelheim International GmbH Production and Growth Rate

Figure Boehringer Ingelheim International GmbH Market Revenue ($) Market Share 2015-2020

Table ViiV Healthcare Company Profile

Table ViiV Healthcare Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure ViiV Healthcare Production and Growth Rate

Figure ViiV Healthcare Market Revenue ($) Market Share 2015-2020

Table Johnson & Johnson Company Profile

Table Johnson & Johnson Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Johnson & Johnson Production and Growth Rate

Figure Johnson & Johnson Market Revenue ($) Market Share 2015-2020

Table Bristol-Myers Squibb Company Profile

Table Bristol-Myers Squibb Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)

Figure Bristol-Myers Squibb Production and Growth Rate

Figure Bristol-Myers Squibb Market Revenue ($) Market Share 2015-2020

Table Global HIV Therapeutics Sales by Types (2015-2020)

Table Global HIV Therapeutics Sales Share by Types (2015-2020)

Table Global HIV Therapeutics Revenue ($) by Types (2015-2020)

Table Global HIV Therapeutics Revenue Share by Types (2015-2020)

Table Global HIV Therapeutics Price ($) by Types (2015-2020)

Table Global HIV Therapeutics Market Forecast Sales by Types (2020-2025)

Table Global HIV Therapeutics Market Forecast Sales Share by Types (2020-2025)

Table Global HIV Therapeutics Market Forecast Revenue ($) by Types (2020-2025)

Table Global HIV Therapeutics Market Forecast Revenue Share by Types (2020-2025)

Figure Global Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Sales and Growth Rate (2015-2020)

Figure Global Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) Price (2015-2020)

Figure Global Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Sales and Growth Rate (2015-2020)

Figure Global Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Price (2015-2020)

Figure Global Entry and Fusion Inhibitors Sales and Growth Rate (2015-2020)

Figure Global Entry and Fusion Inhibitors Price (2015-2020)

Figure Global Protease Inhibitors (PIs) Sales and Growth Rate (2015-2020)

Figure Global Protease Inhibitors (PIs) Price (2015-2020)

Figure Global Integrase Inhibitors Sales and Growth Rate (2015-2020)

Figure Global Integrase Inhibitors Price (2015-2020)

Figure Global Coreceptor Antagonists Sales and Growth Rate (2015-2020)

Figure Global Coreceptor Antagonists Price (2015-2020)

Figure Global HIV Therapeutics Market Revenue ($) and Growth Rate Forecast of Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) (2020-2025)

Figure Global HIV Therapeutics Sales and Growth Rate Forecast of Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs) (2020-2025)

Figure Global HIV Therapeutics Market Revenue ($) and Growth Rate Forecast of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) (2020-2025)

Figure Global HIV Therapeutics Sales and Growth Rate Forecast of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) (2020-2025)

Figure Global HIV Therapeutics Market Revenue ($) and Growth Rate Forecast of Entry and Fusion Inhibitors (2020-2025)

Figure Global HIV Therapeutics Sales and Growth Rate Forecast of Entry and Fusion Inhibitors (2020-2025)

Figure Global HIV Therapeutics Market Revenue ($) and Growth Rate Forecast of Protease Inhibitors (PIs) (2020-2025)

Figure Global HIV Therapeutics Sales and Growth Rate Forecast of Protease Inhibitors (PIs) (2020-2025)

Figure Global HIV Therapeutics Market Revenue ($) and Growth Rate Forecast of Integrase Inhibitors (2020-2025)

Figure Global HIV Therapeutics Sales and Growth Rate Forecast of Integrase Inhibitors (2020-2025)

Figure Global HIV Therapeutics Market Revenue ($) and Growth Rate Forecast of Coreceptor Antagonists (2020-2025)

Figure Global HIV Therapeutics Sales and Growth Rate Forecast of Coreceptor Antagonists (2020-2025)

Table Global HIV Therapeutics Sales by Applications (2015-2020)

Table Global HIV Therapeutics Sales Share by Applications (2015-2020)

Table Global HIV Therapeutics Revenue ($) by Applications (2015-2020)

Table Global HIV Therapeutics Revenue Share by Applications (2015-2020)

Table Global HIV Therapeutics Market Forecast Sales by Applications (2020-2025)

Table Global HIV Therapeutics Market Forecast Sales Share by Applications (2020-2025)

Table Global HIV Therapeutics Market Forecast Revenue ($) by Applications (2020-2025)

Table Global HIV Therapeutics Market Forecast Revenue Share by Applications (2020-2025)

Figure Global Hospitals Sales and Growth Rate (2015-2020)

Figure Global Hospitals Price (2015-2020)

Figure Global Clinics Sales and Growth Rate (2015-2020)

Figure Global Clinics Price (2015-2020)

Figure Global Labs Sales and Growth Rate (2015-2020)

Figure Global Labs Price (2015-2020)

Figure Global HIV Therapeutics Market Revenue ($) and Growth Rate Forecast of Hospitals (2020-2025)

Figure Global HIV Therapeutics Sales and Growth Rate Forecast of Hospitals (2020-2025)

Figure Global HIV Therapeutics Market Revenue ($) and Growth Rate Forecast of Clinics (2020-2025)

Figure Global HIV Therapeutics Sales and Growth Rate Forecast of Clinics (2020-2025)

Figure Global HIV Therapeutics Market Revenue ($) and Growth Rate Forecast of Labs (2020-2025)

Figure Global HIV Therapeutics Sales and Growth Rate Forecast of Labs (2020-2025)

Figure Global HIV Therapeutics Sales and Growth Rate (2015-2020)

Table Global HIV Therapeutics Sales by Regions (2015-2020)

Table Global HIV Therapeutics Sales Market Share by Regions (2015-2020)

Figure Global HIV Therapeutics Sales Market Share by Regions in 2019

Figure Global HIV Therapeutics Revenue and Growth Rate (2015-2020)

Table Global HIV Therapeutics Revenue by Regions (2015-2020)

Table Global HIV Therapeutics Revenue Market Share by Regions (2015-2020)

Figure Global HIV Therapeutics Revenue Market Share by Regions in 2019

Table Global HIV Therapeutics Market Forecast Sales by Regions (2020-2025)

Table Global HIV Therapeutics Market Forecast Sales Share by Regions (2020-2025)

Table Global HIV Therapeutics Market Forecast Revenue ($) by Regions (2020-2025)

Table Global HIV Therapeutics Market Forecast Revenue Share by Regions (2020-2025)

Figure North America HIV Therapeutics Market Sales and Growth Rate (2015-2020)

Figure North America HIV Therapeutics Market Revenue and Growth Rate (2015-2020)

Figure North America HIV Therapeutics Market Forecast Sales (2020-2025)

Figure North America HIV Therapeutics Market Forecast Revenue ($) (2020-2025)

Figure North America COVID-19 Status

Figure U.S. HIV Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Canada HIV Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Mexico HIV Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Europe HIV Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Europe HIV Therapeutics Market Revenue and Growth Rate (2015-2020)

Figure Europe HIV Therapeutics Market Forecast Sales (2020-2025)

Figure Europe HIV Therapeutics Market Forecast Revenue ($) (2020-2025)

Figure Europe COVID-19 Status

Figure Germany HIV Therapeutics Market Sales and Growth Rate (2015-2020)

Figure United Kingdom HIV Therapeutics Market Sales and Growth Rate (2015-2020)

Figure France HIV Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Italy HIV Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Spain HIV Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Russia HIV Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific HIV Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Asia-Pacific HIV Therapeutics Market Revenue and Growth Rate (2015-2020)

Figure Asia-Pacific HIV Therapeutics Market Forecast Sales (2020-2025)

Figure Asia-Pacific HIV Therapeutics Market Forecast Revenue ($) (2020-2025)

Figure Asia Pacific COVID-19 Status

Figure China HIV Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Japan HIV Therapeutics Market Sales and Growth Rate (2015-2020)

Figure South Korea HIV Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Australia HIV Therapeutics Market Sales and Growth Rate (2015-2020)

Figure India HIV Therapeutics Market Sales and Growth Rate (2015-2020)

Figure South America HIV Therapeutics Market Sales and Growth Rate (2015-2020)

Figure South America HIV Therapeutics Market Revenue and Growth Rate (2015-2020)

Figure South America HIV Therapeutics Market Forecast Sales (2020-2025)

Figure South America HIV Therapeutics Market Forecast Revenue ($) (2020-2025)

Figure Brazil HIV Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Argentina HIV Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Columbia HIV Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa HIV Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Middle East and Africa HIV Therapeutics Market Revenue and Growth Rate (2015-2020)

Figure Middle East and Africa HIV Therapeutics Market Forecast Sales (2020-2025)

Figure Middle East and Africa HIV Therapeutics Market Forecast Revenue ($) (2020-2025)

Figure UAE HIV Therapeutics Market Sales and Growth Rate (2015-2020)

Figure Egypt HIV Therapeutics Market Sales and Growth Rate (2015-2020)

Figure South Africa HIV Therapeutics Market Sales and Growth Rate (2015-2020)

The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS). AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Without treatment, average survival time after infection with HIV is estimated to be 9 to 11 years, depending on the HIV subtype. In most cases, HIV is a sexually transmitted infection and occurs by contact with or transfer of blood, pre-ejaculate, semen, and vaginal fluids. Non-sexual transmission can occur from an infected mother to her infant during pregnancy, during childbirth by exposure to her blood or vaginal fluid, and through breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus within infected immune cells.
Based on the HIV Therapeutics market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.

In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.
In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.
In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.

Key players in the global HIV Therapeutics market covered in Chapter 5:
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline
AbbVie
Teva Pharmaceutical Industries Ltd.
Merck & Co.
Pfizer
Gilead Sciences
Cipla Limited
Boehringer Ingelheim International GmbH
ViiV Healthcare
Johnson & Johnson
Bristol-Myers Squibb

In Chapter 6, on the basis of types, the HIV Therapeutics market from 2015 to 2025 is primarily split into:
Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Entry and Fusion Inhibitors
Protease Inhibitors (PIs)
Integrase Inhibitors
Coreceptor Antagonists

In Chapter 7, on the basis of applications, the HIV Therapeutics market from 2015 to 2025 covers:
Hospitals
Clinics
Labs

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:
North America (Covered in Chapter 9)
United States
Canada
Mexico
Europe (Covered in Chapter 10)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 11)
China
Japan
South Korea
Australia
India
South America (Covered in Chapter 12)
Brazil
Argentina
Columbia
Middle East and Africa (Covered in Chapter 13)
UAE
Egypt
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025